experts respond to the fda’s approval of aducanumab | livetalk | being patient
Published 3 years ago • 2.4K plays • Length 35:03Download video MP4
Download video MP3
Similar videos
-
2:23
experts responds to fda approval of aducanumab | being patient
-
33:06
the implications of fda's decision on aducanumab | braintalk | being patient
-
27:33
perspective of the first patient to receive aduhelm in clinical practice | livetalk | being patient
-
40:31
boosting our immune system to treat alzheimer's disease | live talk | being patient
-
32:51
where’s our alzheimer's cure? an inside look at what’s taking so long | livetalk | being patient
-
33:50
a deep dive into the investigational alzheimer’s drug donanemab | livetalk | being patient
-
59:52
a closer look at the infectious theory of alzheimer's | livetalk | being patient
-
30:55
pocket talk | beyond memory: the many faces of alzheimer's disease | 7/19/2024
-
26:16
what does an alzheimer's drug relaunch mean for a cure? | brain talks | being patient
-
50:40
navigating life after an alzheimer's diagnosis as a retired physician | livetalk | being patient
-
28:17
the challenges and advances in diagnosing alzheimer's | livetalk | being patient
-
3:19
where’s our alzheimer's cure? an inside look at what’s taking so long | livetalk | being patient
-
5:59
aduhelm is fda approved for alzheimer's, but does it work?
-
25:03
the pros and cons of alzheimer's genetic testing | livetalk | being patient
-
57:36
rethinking alzheimer’s and the path toward a more brain healthy society | livetalk | being patient
-
40:38
alzheimer’s or not? still uncertain a decade after diagnosis | livetalk | being patient
-
9:14
discussing aducanumab with alzheimer's disease experts | healthy living with mci special segment
-
22:44
rewriting the narrative of a relationship through caregiving | livetalk | being patient
-
6:00
why the fda approved a controversial alzheimer's drug